> 0 1 0 1 O
= 1 2 1 2 O
18 2 4 2 4 B-lower_bound
years 5 10 5 10 I-lower_bound
of 11 13 11 13 O
age 14 17 14 17 B-age
( 18 19 18 19 O
at 19 21 19 21 O
the 22 25 22 25 O
time 26 30 26 30 O
consent 31 38 31 38 O
is 39 41 39 41 O
obtained 42 50 42 50 O
) 50 51 50 51 O

A 0 1 52 53 O
2 2 3 54 55 B-upper_bound
week 4 8 56 60 I-upper_bound
or 9 11 61 63 O
less 12 16 64 68 O
treatment 17 26 69 78 B-treatment
( 27 28 79 80 O
enzalutamide 28 40 80 92 B-treatment
) 40 41 92 93 O
holiday 42 49 94 101 O
will 50 54 102 106 O
be 55 57 107 109 O
permitted 58 67 110 119 O
prior 68 73 120 125 O
to 74 76 126 128 O
initiating 77 87 129 139 O
study 88 93 140 145 B-treatment
treatment 94 103 146 155 I-treatment

A 0 1 156 157 O
positive 2 10 158 166 O
test 11 15 167 171 O
for 16 19 172 175 O
human 20 25 176 181 B-chronic_disease
immunodeficiency 26 42 182 198 I-chronic_disease
virus 43 48 199 204 I-chronic_disease
( 49 50 205 206 I-chronic_disease
HIV 50 53 206 209 I-chronic_disease
) 53 54 209 210 I-chronic_disease
antibody 55 63 211 219 O
( 64 65 220 221 O
testing 65 72 221 228 O
at 73 75 229 231 O
time 76 80 232 236 O
of 81 83 237 239 O
screening 84 93 240 249 O
is 94 96 250 252 O
not 97 100 253 256 O
required 101 109 257 265 O
) 109 110 265 266 O

Active 0 6 267 273 B-chronic_disease
peptic 7 13 274 280 I-chronic_disease
ulcer 14 19 281 286 I-chronic_disease
disease 20 27 287 294 I-chronic_disease
or 28 30 295 297 O
history 31 38 298 305 O
of 39 41 306 308 O
abdominal 42 51 309 318 B-chronic_disease
fistula 52 59 319 326 I-chronic_disease
, 59 60 326 327 O
GI 61 63 328 330 B-chronic_disease
perforation 64 75 331 342 I-chronic_disease
, 75 76 342 343 O
or 77 79 344 346 O
intra 80 85 347 352 B-chronic_disease
abdominal 86 95 353 362 I-chronic_disease
abscess 96 103 363 370 I-chronic_disease
within 104 110 371 377 O
28 111 113 378 380 B-upper_bound
days 114 118 381 385 I-upper_bound
prior 119 124 386 391 I-upper_bound
to 125 127 392 394 O
enrolment 128 137 395 404 O

Any 0 3 405 408 O
> 4 5 409 410 O
= 5 6 410 411 O
Grade 6 11 411 416 B-lower_bound
2 12 13 417 418 I-lower_bound
hypophosphatemia 14 30 419 435 B-clinical_variable
( 31 32 436 437 O
per 32 35 437 440 O
CTCAE 36 41 441 446 O
v4.0 42 46 447 451 O
) 46 47 451 452 O
at 48 50 453 455 O
the 51 54 456 459 O
time 55 59 460 464 O
of 60 62 465 467 O
enrolment 63 72 468 477 O

Any 0 3 478 481 O
serious 4 11 482 489 O
and/or 12 18 490 496 O
unstable 19 27 497 505 O
pre 28 31 506 509 O
- 31 32 509 510 O
existing 32 40 510 518 O
medical 41 48 519 526 O
, 48 49 526 527 O
psychiatric 50 61 528 539 B-chronic_disease
disorder 62 70 540 548 I-chronic_disease
or 71 73 549 551 O
other 74 79 552 557 O
conditions 80 90 558 568 O
that 91 95 569 573 O
could 96 101 574 579 O
interfere 102 111 580 589 O
with 112 116 590 594 O
subject 117 124 595 602 O
's 124 126 602 604 O
safety 127 133 605 611 O
, 133 134 611 612 O
obtaining 135 144 613 622 O
informed 145 153 623 631 O
consent 154 161 632 639 O
or 162 164 640 642 O
compliance 165 175 643 653 O
to 176 178 654 656 O
the 179 182 657 660 O
study 183 188 661 666 O
procedures 189 199 667 677 O

Any 0 3 678 681 O
unresolved 4 14 682 692 O
> 15 16 693 694 O
= 16 17 694 695 O
Grade 17 22 695 700 B-lower_bound
2 23 24 701 702 I-lower_bound
( 25 26 703 704 O
per 26 29 704 707 O
CTCAE 30 35 708 713 O
v 36 37 714 715 O
4.0 38 41 716 719 O
) 41 42 719 720 O
toxicity 43 51 721 729 B-clinical_variable
from 52 56 730 734 O
previous 57 65 735 743 B-treatment
anti 66 70 744 748 I-treatment
- 70 71 748 749 I-treatment
cancer 71 77 749 755 I-treatment
therapy 78 85 756 763 I-treatment
at 86 88 764 766 O
the 89 92 767 770 O
time 93 97 771 775 O
of 98 100 776 778 O
enrollment 101 111 779 789 O

Clinically 0 10 790 800 O
significant 11 22 801 812 O
electrocardiogram 23 40 813 830 B-treatment
abnormalities 41 54 831 844 O
including 55 64 845 854 O
second 65 71 855 861 B-chronic_disease
degree 72 78 862 868 I-chronic_disease
( 79 80 869 870 I-chronic_disease
Type 80 84 870 874 I-chronic_disease
II 85 87 875 877 I-chronic_disease
) 87 88 877 878 I-chronic_disease
or 89 91 879 881 I-chronic_disease
third 92 97 882 887 I-chronic_disease
degree 98 104 888 894 I-chronic_disease
atrioventricular 105 121 895 911 I-chronic_disease
block 122 127 912 917 I-chronic_disease

Completed 0 9 918 927 O
at 10 12 928 930 O
least 13 18 931 936 O
12 19 21 937 939 B-lower_bound
weeks 22 27 940 945 I-lower_bound
of 28 30 946 948 O
prior 31 36 949 954 B-treatment
continuous 37 47 955 965 I-treatment
therapy 48 55 966 973 I-treatment
with 56 60 974 978 I-treatment
enzalutamide 61 73 979 991 I-treatment

Current 0 7 992 999 O
use 8 11 1000 1003 O
of 12 14 1004 1006 O
or 15 17 1007 1009 O
anticipated 18 29 1010 1021 O
requirement 30 41 1022 1033 O
during 42 48 1034 1040 O
the 49 52 1041 1044 O
study 53 58 1045 1050 O
of 59 61 1051 1053 O
prohibited 62 72 1054 1064 O
medication(s 73 85 1065 1077 B-treatment
) 85 86 1077 1078 I-treatment
( 87 88 1079 1080 O
any 88 91 1080 1083 O
investigational 92 107 1084 1099 B-treatment
drug(s 108 114 1100 1106 I-treatment
) 114 115 1106 1107 I-treatment
, 115 116 1107 1108 O
Other 117 122 1109 1114 O
anti 123 127 1115 1119 B-treatment
- 127 128 1119 1120 I-treatment
cancer 128 134 1120 1126 I-treatment
therapy 135 142 1127 1134 I-treatment
( 143 144 1135 1136 O
chemotherapy 144 156 1136 1148 B-treatment
, 156 157 1148 1149 O
radiation 158 167 1150 1159 B-treatment
therapy 168 175 1160 1167 I-treatment
, 175 176 1167 1168 O
immunotherapy 177 190 1169 1182 B-treatment
, 190 191 1182 1183 O
biologic 192 200 1184 1192 B-treatment
therapy 201 208 1193 1200 I-treatment
, 208 209 1200 1201 O
or 210 212 1202 1204 O
hormone 213 220 1205 1212 B-treatment
therapy 221 228 1213 1220 I-treatment
other 229 234 1221 1226 O
than 235 239 1227 1231 O
for 240 243 1232 1235 O
replacement 244 255 1236 1247 O
) 255 256 1247 1248 O
, 256 257 1248 1249 O
AR 258 260 1250 1252 B-treatment
antagonists 261 272 1253 1264 I-treatment
( 273 274 1265 1266 O
e.g. 274 278 1266 1270 O
, 278 279 1270 1271 O
bicalutamide 280 292 1272 1284 B-treatment
, 292 293 1284 1285 O
flutamide 294 303 1286 1295 B-treatment
, 303 304 1295 1296 O
nilutamide 305 315 1297 1307 B-treatment
) 315 316 1307 1308 O
, 316 317 1308 1309 O
5 318 319 1310 1311 B-treatment
- 319 320 1311 1312 I-treatment
alpha 320 325 1312 1317 I-treatment
reductase 326 335 1318 1327 I-treatment
inhibitors 336 346 1328 1338 I-treatment
( 347 348 1339 1340 O
e.g. 348 352 1340 1344 O
, 352 353 1344 1345 O
finasteride 354 365 1346 1357 B-treatment
, 365 366 1357 1358 O
dutasteride 367 378 1359 1370 B-treatment
) 378 379 1370 1371 O
, 379 380 1371 1372 O
Androgens 381 390 1373 1382 B-treatment
( 391 392 1383 1384 O
e.g. 392 396 1384 1388 O
, 396 397 1388 1389 O
testosterone 398 410 1390 1402 B-treatment
, 410 411 1402 1403 O
dihydroepiandrosterone 412 434 1404 1426 B-treatment
) 434 435 1426 1427 O
, 435 436 1427 1428 O
Herbal 437 443 1429 1435 B-treatment
medication(s 444 456 1436 1448 I-treatment
) 456 457 1448 1449 I-treatment
that 458 462 1450 1454 O
may 463 466 1455 1458 O
affect 467 473 1459 1465 O
PSA 474 477 1466 1469 O
levels 478 484 1470 1476 O
( 485 486 1477 1478 O
e.g. 486 490 1478 1482 O
, 490 491 1482 1483 O
saw 492 495 1484 1487 B-treatment
palmetto 496 504 1488 1496 I-treatment
) 504 505 1496 1497 O
, 505 506 1497 1498 O
Other 507 512 1499 1504 O
herbal 513 519 1505 1511 B-treatment
medications 520 531 1512 1523 I-treatment
including 532 541 1524 1533 O
, 541 542 1533 1534 O
but 543 546 1535 1538 O
not 547 550 1539 1542 O
limited 551 558 1543 1550 O
to 559 561 1551 1553 O
: 561 562 1553 1554 O
St. 563 566 1555 1558 B-treatment
John 567 571 1559 1563 I-treatment
's 571 573 1563 1565 I-treatment
wort 574 578 1566 1570 I-treatment
, 578 579 1570 1571 O
kava 580 584 1572 1576 B-treatment
, 584 585 1576 1577 I-treatment
ephedra 586 593 1578 1585 I-treatment
( 594 595 1586 1587 I-treatment
ma 595 597 1587 1589 I-treatment
huang 598 603 1590 1595 I-treatment
) 603 604 1595 1596 I-treatment
, 604 605 1596 1597 O
gingko 606 612 1598 1604 B-treatment
biloba 613 619 1605 1611 I-treatment
, 619 620 1611 1612 O
yohimbe 621 628 1613 1620 B-treatment
and 629 632 1621 1624 O
ginseng 633 640 1625 1632 B-treatment
) 640 641 1632 1633 O

Eastern 0 7 1634 1641 B-clinical_variable
Cooperative 8 19 1642 1653 I-clinical_variable
Oncology 20 28 1654 1662 I-clinical_variable
Group 29 34 1663 1668 I-clinical_variable
( 35 36 1669 1670 I-clinical_variable
ECOG 36 40 1670 1674 I-clinical_variable
) 40 41 1674 1675 I-clinical_variable
performance 42 53 1676 1687 I-clinical_variable
status 54 60 1688 1694 I-clinical_variable
of 61 63 1695 1697 O
0 64 65 1698 1699 B-lower_bound
or 66 68 1700 1702 O
1 69 70 1703 1704 B-upper_bound

Evidence 0 8 1705 1713 O
of 9 11 1714 1716 O
severe 12 18 1717 1723 O
or 19 21 1724 1726 O
uncontrolled 22 34 1727 1739 O
systemic 35 43 1740 1748 B-chronic_disease
diseases 44 52 1749 1757 I-chronic_disease
( 53 54 1758 1759 O
e.g. 54 58 1759 1763 O
, 58 59 1763 1764 O
unstable 60 68 1765 1773 O
or 69 71 1774 1776 O
uncompensated 72 85 1777 1790 O
respiratory 86 97 1791 1802 B-chronic_disease
, 97 98 1802 1803 O
hepatic 99 106 1804 1811 B-chronic_disease
, 106 107 1811 1812 O
renal 108 113 1813 1818 B-chronic_disease
or 114 116 1819 1821 O
cardiac 117 124 1822 1829 B-chronic_disease
disease 125 132 1830 1837 I-chronic_disease
) 132 133 1837 1838 O

Exposure 0 8 1839 1847 O
to 9 11 1848 1850 O
more 12 16 1851 1855 O
than 17 21 1856 1860 O
4 22 23 1861 1862 B-lower_bound
investigational 24 39 1863 1878 B-treatment
medicinal 40 49 1879 1888 I-treatment
products 50 58 1889 1897 I-treatment
within 59 65 1898 1904 O
12 66 68 1905 1907 B-upper_bound
months 69 75 1908 1914 I-upper_bound
prior 76 81 1915 1920 I-upper_bound
to 82 84 1921 1923 O
the 85 88 1924 1927 O
first 89 94 1928 1933 O
dose 95 99 1934 1938 O
of 100 102 1939 1941 O
study 103 108 1942 1947 O
treatment 109 118 1948 1957 B-treatment

Have 0 4 1958 1962 O
a 5 6 1963 1964 O
known 7 12 1965 1970 O
immediate 13 22 1971 1980 O
or 23 25 1981 1983 O
delayed 26 33 1984 1991 O
hypersensitivity 34 50 1992 2008 O
reaction 51 59 2009 2017 O
or 60 62 2018 2020 O
idiosyncrasy 63 75 2021 2033 O
to 76 78 2034 2036 O
drugs 79 84 2037 2042 O
chemically 85 95 2043 2053 O
related 96 103 2054 2061 O
to 104 106 2062 2064 O
GSK2636771or 107 119 2065 2077 B-allergy_name
enzalutamide 120 132 2078 2090 B-allergy_name
or 133 135 2091 2093 O
excipients 136 146 2094 2104 O

Histologically 0 14 2105 2119 O
or 15 17 2120 2122 O
cytologically 18 31 2123 2136 O
confirmed 32 41 2137 2146 O
diagnosis 42 51 2147 2156 O
of 52 54 2157 2159 O
prostate 55 63 2160 2168 B-cancer
adenocarcinoma 64 78 2169 2183 I-cancer
, 78 79 2183 2184 O
surgically 80 90 2185 2195 B-treatment
castrated 91 100 2196 2205 I-treatment
or 101 103 2206 2208 I-treatment
continuous 104 114 2209 2219 I-treatment
medical 115 122 2220 2227 I-treatment
castration 123 133 2228 2238 I-treatment
( 134 135 2239 2240 O
for 135 138 2240 2243 O
> 139 140 2244 2245 O
= 140 141 2245 2246 O
8 141 142 2246 2247 B-lower_bound
weeks 143 148 2248 2253 I-lower_bound
prior 149 154 2254 2259 I-lower_bound
to 155 157 2260 2262 O
Screening 158 167 2263 2272 O
) 167 168 2272 2273 O

History 0 7 2274 2281 O
of 8 10 2282 2284 O
congenital 11 21 2285 2295 O
platelet 22 30 2296 2304 O
function 31 39 2305 2313 O
defect 40 46 2314 2320 O
( 47 48 2321 2322 O
e.g. 48 52 2322 2326 O
, 52 53 2326 2327 O
Bernard 54 61 2328 2335 B-chronic_disease
- 61 62 2335 2336 I-chronic_disease
Soulier 62 69 2336 2343 I-chronic_disease
syndrome 70 78 2344 2352 I-chronic_disease
, 78 79 2352 2353 O
Chediak 80 87 2354 2361 B-chronic_disease
- 87 88 2361 2362 I-chronic_disease
Higashi 88 95 2362 2369 I-chronic_disease
syndrome 96 104 2370 2378 I-chronic_disease
, 104 105 2378 2379 O
Glanzmann 106 115 2380 2389 B-chronic_disease
thrombasthenia 116 130 2390 2404 I-chronic_disease
, 130 131 2404 2405 O
storage 132 139 2406 2413 B-chronic_disease
pool 140 144 2414 2418 I-chronic_disease
defect 145 151 2419 2425 I-chronic_disease
) 151 152 2425 2426 O

History 0 7 2427 2434 O
of 8 10 2435 2437 O
seizure 11 18 2438 2445 B-chronic_disease
or 19 21 2446 2448 O
any 22 25 2449 2452 O
condition 26 35 2453 2462 O
that 36 40 2463 2467 O
may 41 44 2468 2471 O
predispose 45 55 2472 2482 O
subject 56 63 2483 2490 O
to 64 66 2491 2493 O
seizure 67 74 2494 2501 O
( 75 76 2502 2503 O
e.g. 76 80 2503 2507 O
, 80 81 2507 2508 O
prior 82 87 2509 2514 B-chronic_disease
cortical 88 96 2515 2523 I-chronic_disease
stroke 97 103 2524 2530 I-chronic_disease
or 104 106 2531 2533 O
significant 107 118 2534 2545 O
brain 119 124 2546 2551 B-chronic_disease
trauma 125 131 2552 2558 I-chronic_disease
) 131 132 2558 2559 O
. 132 133 2559 2560 O
History 134 141 2561 2568 O
of 142 144 2569 2571 O
loss 145 149 2572 2576 O
of 150 152 2577 2579 O
consciousness 153 166 2580 2593 O
or 167 169 2594 2596 O
transient 170 179 2597 2606 B-chronic_disease
ischemic 180 188 2607 2615 I-chronic_disease
attack 189 195 2616 2622 I-chronic_disease
within 196 202 2623 2629 O
12 203 205 2630 2632 B-upper_bound
months 206 212 2633 2639 I-upper_bound
of 213 215 2640 2642 O
randomization 216 229 2643 2656 O

History 0 7 2657 2664 O
or 8 10 2665 2667 O
evidence 11 19 2668 2676 O
of 20 22 2677 2679 O
cardiovascular 23 37 2680 2694 B-chronic_disease
risk 38 42 2695 2699 O

Investigational 0 15 2700 2715 B-treatment
drug(s 16 22 2716 2722 I-treatment
) 22 23 2722 2723 I-treatment
within 24 30 2724 2730 O
30 31 33 2731 2733 B-upper_bound
days 34 38 2734 2738 I-upper_bound
or 39 41 2739 2741 O
5 42 43 2742 2743 B-upper_bound
half 44 48 2744 2748 I-upper_bound
- 48 49 2748 2749 I-upper_bound
lives 49 54 2749 2754 I-upper_bound
, 54 55 2754 2755 O
whichever 56 65 2756 2765 O
is 66 68 2766 2768 O
longer 69 75 2769 2775 O
, 75 76 2775 2776 O
prior 77 82 2777 2782 O
to 83 85 2783 2785 O
enrollment 86 96 2786 2796 O

Known 0 5 2797 2802 O
active 6 12 2803 2809 B-chronic_disease
infection 13 22 2810 2819 I-chronic_disease
requiring 23 32 2820 2829 O
intravenous 33 44 2830 2841 B-treatment
( 45 46 2842 2843 I-treatment
IV 46 48 2843 2845 I-treatment
) 48 49 2845 2846 I-treatment
or 50 52 2847 2849 O
oral 53 57 2850 2854 B-treatment
anti 58 62 2855 2859 I-treatment
- 62 63 2859 2860 I-treatment
infective 63 72 2860 2869 I-treatment
treatment 73 82 2870 2879 I-treatment

Male 0 4 2880 2884 B-gender
subject 5 12 2885 2892 I-gender
with 13 17 2893 2897 O
a 18 19 2898 2899 O
female 20 26 2900 2906 B-gender
partner 27 34 2907 2914 I-gender
of 35 37 2915 2917 O
childbearing 38 50 2918 2930 O
potential 51 60 2931 2940 O
must 61 65 2941 2945 O
have 66 70 2946 2950 O
either 71 77 2951 2957 O
had 78 81 2958 2961 O
a 82 83 2962 2963 O
prior 84 89 2964 2969 B-treatment
vasectomy 90 99 2970 2979 I-treatment
or 100 102 2980 2982 O
agree 103 108 2983 2988 B-contraception_consent
to 109 111 2989 2991 I-contraception_consent
use 112 115 2992 2995 I-contraception_consent
effective 116 125 2996 3005 I-contraception_consent
contraception 126 139 3006 3019 I-contraception_consent
from 140 144 3020 3024 O
time 145 149 3025 3029 O
of 150 152 3030 3032 O
Screening 153 162 3033 3042 O
until 163 168 3043 3048 O
3 169 170 3049 3050 B-upper_bound
months 171 177 3051 3057 I-upper_bound
after 178 183 3058 3063 I-upper_bound
the 184 187 3064 3067 O
last 188 192 3068 3072 O
dose 193 197 3073 3077 O
of 198 200 3078 3080 O
study 201 206 3081 3086 B-treatment
treatment 207 216 3087 3096 I-treatment

Males 0 5 3097 3102 B-gender

Most 0 4 3103 3107 O
recent 5 11 3108 3114 O
enzalutamide 12 24 3115 3127 B-treatment
dose 25 29 3128 3132 O
received 30 38 3133 3141 O
is 39 41 3142 3144 O
160 42 45 3145 3148 O
mg 46 48 3149 3151 O
once 49 53 3152 3156 O
daily 54 59 3157 3162 O
with 60 64 3163 3167 O
no 65 67 3168 3170 O
change 68 74 3171 3177 O
in 75 77 3178 3180 O
dose 78 82 3181 3185 O
for 83 86 3186 3189 O
at 87 89 3190 3192 O
least 90 95 3193 3198 O
2 96 97 3199 3200 B-lower_bound
weeks 98 103 3201 3206 I-lower_bound
prior 104 109 3207 3212 I-lower_bound
to 110 112 3213 3215 O
Screening 113 122 3216 3225 O

Must 0 4 3226 3230 O
have 5 9 3231 3235 O
a 10 11 3236 3237 O
QT 12 14 3238 3240 O
interval 15 23 3241 3249 O
corrected 24 33 3250 3259 O
for 34 37 3260 3263 O
heart 38 43 3264 3269 O
rate 44 48 3270 3274 O
according 49 58 3275 3284 O
to 59 61 3285 3287 O
Fridericia 62 72 3288 3298 B-clinical_variable
's 72 74 3298 3300 I-clinical_variable
formula 75 82 3301 3308 I-clinical_variable
( 83 84 3309 3310 I-clinical_variable
QTcF 84 88 3310 3314 I-clinical_variable
) 88 89 3314 3315 I-clinical_variable
< 90 91 3316 3317 O
470 91 94 3317 3320 B-upper_bound
milli 95 100 3321 3326 I-upper_bound
seconds 101 108 3327 3334 I-upper_bound
( 109 110 3335 3336 I-upper_bound
msec 110 114 3336 3340 I-upper_bound
) 114 115 3340 3341 I-upper_bound
or 116 118 3342 3344 O
< 119 120 3345 3346 O
480 120 123 3346 3349 B-upper_bound
msec 124 128 3350 3354 I-upper_bound
with 129 133 3355 3359 O
bundle 134 140 3360 3366 B-chronic_disease
branch 141 147 3367 3373 I-chronic_disease
block 148 153 3374 3379 I-chronic_disease

PSA 0 3 3380 3383 O
progression 4 15 3384 3395 O
defined 16 23 3396 3403 O
by 24 26 3404 3406 O
PCWG2 27 32 3407 3412 O
criteria 33 41 3413 3421 O
or 42 44 3422 3424 O
soft 45 49 3425 3429 O
tissue 50 56 3430 3436 O
disease 57 64 3437 3444 O
progression 65 76 3445 3456 O
defined 77 84 3457 3464 O
by 85 87 3465 3467 O
RECIST 88 94 3468 3474 O
1.1 95 98 3475 3478 O
or 99 101 3479 3481 O
bone 102 106 3482 3486 B-chronic_disease
disease 107 114 3487 3494 I-chronic_disease
progression 115 126 3495 3506 O
defined 127 134 3507 3514 O
by 135 137 3515 3517 O
PCWG2 138 143 3518 3523 O
criteria 144 152 3524 3532 O
Able 153 157 3533 3537 O
to 158 160 3538 3540 O
swallow 161 168 3541 3548 O
and 169 172 3549 3552 O
retain 173 179 3553 3559 O
orally 180 186 3560 3566 O
administered 187 199 3567 3579 O
medication 200 210 3580 3590 B-treatment

PTEN 0 4 3591 3595 B-cancer
deficient 5 14 3596 3605 I-cancer
tumor 15 20 3606 3611 I-cancer
as 21 23 3612 3614 O
documented 24 34 3615 3625 O
from 35 39 3626 3630 O
archival 40 48 3631 3639 O
or 49 51 3640 3642 O
fresh 52 57 3643 3648 O
( 58 59 3649 3650 O
from 59 63 3650 3654 O
biopsy 64 70 3655 3661 B-treatment
) 70 71 3661 3662 O
tumor 72 77 3663 3668 O
tissue 78 84 3669 3675 O
analyzed 85 93 3676 3684 O
by 94 96 3685 3687 O
GlaxoSmithKline 97 112 3688 3703 O
selected 113 121 3704 3712 O
laboratory 122 132 3713 3723 O

Poorly 0 6 3724 3730 O
controlled 7 17 3731 3741 O
hypertension 18 30 3742 3754 B-chronic_disease
( 31 32 3755 3756 O
defined 32 39 3756 3763 O
as 40 42 3764 3766 O
systolic 43 51 3767 3775 B-clinical_variable
blood 52 57 3776 3781 I-clinical_variable
pressure 58 66 3782 3790 I-clinical_variable
of>=150 67 74 3791 3798 O
millimeter 75 85 3799 3809 I-lower_bound
of 86 88 3810 3812 I-lower_bound
mercury 89 96 3813 3820 I-lower_bound
( 97 98 3821 3822 I-lower_bound
mmHg 98 102 3822 3826 I-lower_bound
) 102 103 3826 3827 I-lower_bound
or 104 106 3828 3830 O
diastolic 107 116 3831 3840 B-clinical_variable
blood 117 122 3841 3846 I-clinical_variable
pressure 123 131 3847 3855 I-clinical_variable
of 132 134 3856 3858 O
> 135 136 3859 3860 O
100 136 139 3860 3863 B-lower_bound
mmHg 140 144 3864 3868 I-lower_bound
based 145 150 3869 3874 O
on 151 153 3875 3877 O
a 154 155 3878 3879 O
mean 156 160 3880 3884 O
of 161 163 3885 3887 O
three 164 169 3888 3893 O
measurements 170 182 3894 3906 O
at 183 185 3907 3909 O
approximately 186 199 3910 3923 O
2 200 201 3924 3925 O
- 201 202 3925 3926 O
minute 202 208 3926 3932 O
intervals 209 218 3933 3942 O
) 218 219 3942 3943 O

Presence 0 8 3944 3952 O
of 9 11 3953 3955 O
any 12 15 3956 3959 O
clinically 16 26 3960 3970 O
significant 27 38 3971 3982 O
gastrointestinal 39 55 3983 3999 B-chronic_disease
( 56 57 4000 4001 I-chronic_disease
GI 57 59 4001 4003 I-chronic_disease
) 59 60 4003 4004 I-chronic_disease
abnormality 61 72 4005 4016 I-chronic_disease
or 73 75 4017 4019 O
other 76 81 4020 4025 O
condition(s 82 93 4026 4037 O
) 93 94 4037 4038 O
that 95 99 4039 4043 O
may 100 103 4044 4047 O
alter 104 109 4048 4053 O
absorption 110 120 4054 4064 O
such 121 125 4065 4069 O
as 126 128 4070 4072 O
malabsorption 129 142 4073 4086 B-chronic_disease
syndrome 143 151 4087 4095 I-chronic_disease
or 152 154 4096 4098 O
major 155 160 4099 4104 O
resection 161 170 4105 4114 O
of 171 173 4115 4117 O
the 174 177 4118 4121 O
stomach 178 185 4122 4129 O
or 186 188 4130 4132 O
substantial 189 200 4133 4144 O
portion 201 208 4145 4152 O
of 209 211 4153 4155 O
the 212 215 4156 4159 O
small 216 221 4160 4165 O
intestine 222 231 4166 4175 O

Presence 0 8 4176 4184 O
of 9 11 4185 4187 O
hepatitis 12 21 4188 4197 B-treatment
B 22 23 4198 4199 I-treatment
surface 24 31 4200 4207 I-treatment
antigen 32 39 4208 4215 I-treatment
( 40 41 4216 4217 I-treatment
HBsAg 41 46 4217 4222 I-treatment
) 46 47 4222 4223 I-treatment
, 47 48 4223 4224 O
positive 49 57 4225 4233 O
hepatitis 58 67 4234 4243 B-treatment
C 68 69 4244 4245 I-treatment
antibody 70 78 4246 4254 I-treatment
test 79 83 4255 4259 O
result 84 90 4260 4266 O
at 91 93 4267 4269 O
screening 94 103 4270 4279 O
or 104 106 4280 4282 O
within 107 113 4283 4289 O
3 114 115 4290 4291 B-upper_bound
months 116 122 4292 4298 I-upper_bound
prior 123 128 4299 4304 I-upper_bound
to 129 131 4305 4307 O
first 132 137 4308 4313 O
dose 138 142 4314 4318 O
of 143 145 4319 4321 O
study 146 151 4322 4327 O
treatment 152 161 4328 4337 B-treatment

Previous 0 8 4338 4346 B-treatment
major 9 14 4347 4352 I-treatment
surgery 15 22 4353 4360 I-treatment
within 23 29 4361 4367 O
28 30 32 4368 4370 B-upper_bound
days 33 37 4371 4375 I-upper_bound
prior 38 43 4376 4381 I-upper_bound
to 44 46 4382 4384 O
enrolment 47 56 4385 4394 O

Prior 0 5 4395 4400 O
malignancy 6 16 4401 4411 B-cancer
other 17 22 4412 4417 O
than 23 27 4418 4422 O
CRPC 28 32 4423 4427 B-cancer

Serum 0 5 4428 4433 B-clinical_variable
calcium 6 13 4434 4441 I-clinical_variable
> 14 15 4442 4443 O
= 15 16 4443 4444 O
Grade 16 21 4444 4449 B-lower_bound
1 22 23 4450 4451 I-lower_bound
( 24 25 4452 4453 O
per 25 28 4453 4456 O
CTCAE 29 34 4457 4462 B-clinical_variable
v4.0 35 39 4463 4467 I-clinical_variable
) 39 40 4467 4468 O
at 41 43 4469 4471 O
time 44 48 4472 4476 O
of 49 51 4477 4479 O
enrolment 52 61 4480 4489 O
, 61 62 4489 4490 O
unless 63 69 4491 4497 O
ionized 70 77 4498 4505 O
calcium 78 85 4506 4513 O
is 86 88 4514 4516 O
within 89 95 4517 4523 O
normal 96 102 4524 4530 O
range 103 108 4531 4536 O

Serum 0 5 4537 4542 B-clinical_variable
testosterone 6 18 4543 4555 I-clinical_variable
< 19 20 4556 4557 O
50 20 22 4557 4559 B-upper_bound
nanogram 23 31 4560 4568 I-upper_bound
per 32 35 4569 4572 I-upper_bound
deciliter 36 45 4573 4582 I-upper_bound
( 46 47 4583 4584 I-upper_bound
ng 47 49 4584 4586 I-upper_bound
/ 49 50 4586 4587 I-upper_bound
dL 50 52 4587 4589 I-upper_bound
) 52 53 4589 4590 I-upper_bound
( 54 55 4591 4592 O
1.7 55 58 4592 4595 B-upper_bound
nanomole 59 67 4596 4604 I-upper_bound
per 68 71 4605 4608 I-upper_bound
liter 72 77 4609 4614 I-upper_bound
[ 78 79 4615 4616 I-upper_bound
nM 79 81 4616 4618 I-upper_bound
/ 81 82 4618 4619 I-upper_bound
L 82 83 4619 4620 I-upper_bound
] 83 84 4620 4621 I-upper_bound
) 84 85 4621 4622 O

Subjects 0 8 4623 4631 O
may 9 12 4632 4635 O
remain 13 19 4636 4642 O
on 20 22 4643 4645 O
luteinizing 23 34 4646 4657 B-treatment
hormone 35 42 4658 4665 I-treatment
releasing 43 52 4666 4675 I-treatment
hormone 53 60 4676 4683 I-treatment
( 61 62 4684 4685 I-treatment
LHRH 62 66 4685 4689 I-treatment
) 66 67 4689 4690 I-treatment
agonists 68 76 4691 4699 I-treatment
( 77 78 4700 4701 O
i.e. 78 82 4701 4705 O
, 82 83 4705 4706 O
leuprolide 84 94 4707 4717 B-treatment
, 94 95 4717 4718 O
goserelin 96 105 4719 4728 B-treatment
, 105 106 4728 4729 O
triptorelin 107 118 4730 4741 B-treatment
or 119 121 4742 4744 O
histrelin 122 131 4745 4754 B-treatment
) 131 132 4754 4755 O

Subjects 0 8 4756 4764 O
must 9 13 4765 4769 O
have 14 18 4770 4774 O
prior 19 24 4775 4780 B-treatment
enzalutamide 25 37 4781 4793 I-treatment
treatment 38 47 4794 4803 I-treatment
; 47 48 4803 4804 O
Any 49 52 4805 4808 O
PI3 53 56 4809 4812 B-treatment
K 56 57 4812 4813 I-treatment
, 57 58 4813 4814 O
AKT 59 62 4815 4818 B-treatment
or 63 65 4819 4821 O
mammalian 66 75 4822 4831 B-treatment
target 76 82 4832 4838 I-treatment
of 83 85 4839 4841 I-treatment
rapamycin 86 95 4842 4851 I-treatment
( 96 97 4852 4853 I-treatment
mTOR 97 101 4853 4857 I-treatment
) 101 102 4857 4858 I-treatment
inhibitors 103 113 4859 4869 I-treatment

Subjects 0 8 4870 4878 O
who 9 12 4879 4882 O
have 13 17 4883 4887 O
been 18 22 4888 4892 O
disease 23 30 4893 4900 O
- 30 31 4900 4901 O
free 31 35 4901 4905 O
for 36 39 4906 4909 O
5 40 41 4910 4911 B-upper_bound
years 42 47 4912 4917 I-upper_bound
, 47 48 4917 4918 O
or 49 51 4919 4921 O
subjects 52 60 4922 4930 O
with 61 65 4931 4935 O
a 66 67 4936 4937 O
history 68 75 4938 4945 O
of 76 78 4946 4948 O
completely 79 89 4949 4959 O
resected 90 98 4960 4968 O
non 99 102 4969 4972 B-cancer
- 102 103 4972 4973 I-cancer
melanoma 103 111 4973 4981 I-cancer
skin 112 116 4982 4986 I-cancer
cancer 117 123 4987 4993 I-cancer
or 124 126 4994 4996 O
successfully 127 139 4997 5009 O
treated 140 147 5010 5017 O
in 148 150 5018 5020 B-cancer
situ 151 155 5021 5025 I-cancer
carcinoma 156 165 5026 5035 I-cancer
are 166 169 5036 5039 O
eligible 170 178 5040 5048 O

alopecia 0 8 5049 5057 B-chronic_disease

hemoglobin 0 10 5058 5068 B-clinical_variable
is 11 13 5069 5071 O
> 14 15 5072 5073 O
9.0 15 18 5073 5076 B-lower_bound
g 19 20 5077 5078 I-lower_bound
/ 20 21 5078 5079 I-lower_bound
dL 21 23 5079 5081 I-lower_bound

history 0 7 5082 5089 O
of 8 10 5090 5092 O
myocardial 11 21 5093 5103 B-chronic_disease
infarction 22 32 5104 5114 I-chronic_disease
, 32 33 5114 5115 O
acute 34 39 5116 5121 B-chronic_disease
coronary 40 48 5122 5130 I-chronic_disease
syndromes 49 58 5131 5140 I-chronic_disease
( 59 60 5141 5142 O
including 60 69 5142 5151 O
unstable 70 78 5152 5160 B-chronic_disease
angina 79 85 5161 5167 I-chronic_disease
) 85 86 5167 5168 O
, 86 87 5168 5169 O
coronary 88 96 5170 5178 B-treatment
angioplasty 97 108 5179 5190 I-treatment
, 108 109 5190 5191 O
stenting 110 118 5192 5200 B-treatment
, 118 119 5200 5201 O
or 120 122 5202 5204 O
bypass 123 129 5205 5211 B-treatment
grafting 130 138 5212 5220 I-treatment
within 139 145 5221 5227 O
the 146 149 5228 5231 O
past 150 154 5232 5236 B-upper_bound
6 155 156 5237 5238 I-upper_bound
months 157 163 5239 5245 I-upper_bound
prior 164 169 5246 5251 O
to 170 172 5252 5254 O
enrolment 173 182 5255 5264 O
, 182 183 5264 5265 O
Class 184 189 5266 5271 B-chronic_disease
III 190 193 5272 5275 I-chronic_disease
or 194 196 5276 5278 I-chronic_disease
IV 197 199 5279 5281 I-chronic_disease
heart 200 205 5282 5287 I-chronic_disease
failure 206 213 5288 5295 I-chronic_disease
as 214 216 5296 5298 O
defined 217 224 5299 5306 O
by 225 227 5307 5309 O
the 228 231 5310 5313 O
New 232 235 5314 5317 B-clinical_variable
York 236 240 5318 5322 I-clinical_variable
Heart 241 246 5323 5328 I-clinical_variable
Association 247 258 5329 5340 I-clinical_variable
functional 259 269 5341 5351 O
classification 270 284 5352 5366 O
system 285 291 5367 5373 O
, 291 292 5373 5374 O
LVEF 293 297 5375 5379 B-clinical_variable
below 298 303 5380 5385 O
50 304 306 5386 5388 B-upper_bound
% 306 307 5388 5389 I-upper_bound

known 0 5 5390 5395 O
cardiac 6 13 5396 5403 B-cancer
metastases 14 24 5404 5414 I-cancer

